International Clinical Trial: A prospective, multicenter, randomized, controlled, open-label trial to evaluate the efficacy and safety of Finotonlimab in locally advanced head and neck squamous cell carcinoma

Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117055) titled 'A prospective, multicenter, randomized, controlled, open-label trial to evaluate the efficacy and safety of Finotonlimab in locally advanced head and neck squamous cell carcinoma' on Jan. 19.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Fudan University Shanghai Cancer Center

Condition: Squamous cell carcinoma of the head and neck

Intervention: Experimental Group:Perioperative treatment with Finotonlimab

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2026-02-28

Target Sample Size: Experimental Group:146;Control group:146;

Countries of Recruitment:...